Title: Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes.
Journal: European journal of medicinal chemistry 20120601
338959-60-7
923387-66-0
681222-52-6
681222-66-2
681223-16-5
891476-25-8
109053-87-4 | methyl (3R)-3-hydroxyheptanoate | AA00IXJ4 | MFCD28990655
861207-96-7 | 4-(4-benzylpiperidin-1-yl)-6-methoxypyrimidine-5-carbaldehyde | AA00IXNH | MFCD04124851
767634-07-1 | 1-(2-cyanophenyl)-3-ethylurea | AA00IXQG | MFCD04124907
861211-56-5 | 3-([(6-Chloropyridin-3-yl)methyl](methyl)amino)propanenitrile | AA00IXT6 | MFCD04125025
338414-09-8 | (2E)-3-(4-bromophenyl)-3-oxo-2-{2-[4-(trifluoromethyl)phenyl]hydrazin-1-ylidene}propanal | AA00IXWB | MFCD00975108
315246-86-7 | 3-[(cyanomethyl)sulfanyl]-1-phenyl-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile | AA00IXZ6 | MFCD02328709
338417-85-9 | 3-[(4-chlorophenyl)sulfanyl]-6-phenylpyridazine-4-carbonitrile | AA00IY1Y | MFCD00794554
338748-59-7 | 2-[4-(4-nitrophenyl)piperazin-1-yl]ethyl 4-fluorobenzoate | AA00IY4N | MFCD01315637
866019-39-8 | 2-[2-(3-nitrophenyl)-2-oxoethoxy]benzamide | AA00IY7I | MFCD03787729
338954-09-9 | 4-bromo-N-{[4-(prop-2-en-1-yl)-5-sulfanyl-4H-1,2,4-triazol-3-yl]methyl}benzene-1-sulfonamide | AA00IYAL | MFCD00202313